Alternatives To Brief Summary Outlined In Draft Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
One of FDA's three draft guidances on DTC advertising requests that consumer-friendly language be used. Commissioner McClellan calls proposed brief summary alternatives a "win-win" and suggests manufacturers will be able to reduce their advertising costs as a result.
You may also be interested in...
DTC Print Ads: Package Insert Info Is Out, Drug Facts Box Is In
FDA’s revised draft guidance for disclosing risk information in direct-to-consumer print ads advises against the use of package insert information in the brief summary; suggests Drugs Facts box or Q&A as alternative formats.
GSK/Roche's Boniva Print Ad Uses Question-And-Answer Brief Summary
Print campaign for the osteoporosis agent uses a reprint of the patient information sheet, which is in a Q&A format, instead of traditional brief summary format. The campaign highlights Boniva's unique once-monthly dosing regimen.
GSK/Roche's Boniva Print Ad Uses Question-And-Answer Brief Summary
Print campaign for the osteoporosis agent uses a reprint of the patient information sheet, which is in a Q&A format, instead of traditional brief summary format. The campaign highlights Boniva's unique once-monthly dosing regimen.